vs

Side-by-side financial comparison of LCI INDUSTRIES (LCII) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

LCI INDUSTRIES is the larger business by last-quarter revenue ($932.7M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.0%, a 4.8% gap on every dollar of revenue. On growth, LCI INDUSTRIES posted the faster year-over-year revenue change (16.1% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.8%).

Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

LCII vs MD — Head-to-Head

Bigger by revenue
LCII
LCII
1.9× larger
LCII
$932.7M
$493.8M
MD
Growing faster (revenue YoY)
LCII
LCII
+17.8% gap
LCII
16.1%
-1.7%
MD
Higher net margin
MD
MD
4.8% more per $
MD
6.8%
2.0%
LCII
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-1.8%
LCII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCII
LCII
MD
MD
Revenue
$932.7M
$493.8M
Net Profit
$18.7M
$33.7M
Gross Margin
22.1%
Operating Margin
3.8%
9.9%
Net Margin
2.0%
6.8%
Revenue YoY
16.1%
-1.7%
Net Profit YoY
95.7%
10.5%
EPS (diluted)
$0.79
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCII
LCII
MD
MD
Q4 25
$932.7M
$493.8M
Q3 25
$1.0B
$492.9M
Q2 25
$1.1B
$468.8M
Q1 25
$1.0B
$458.4M
Q4 24
$803.1M
$502.4M
Q3 24
$915.5M
$511.2M
Q2 24
$1.1B
$504.3M
Q1 24
$968.0M
$495.1M
Net Profit
LCII
LCII
MD
MD
Q4 25
$18.7M
$33.7M
Q3 25
$62.5M
$71.7M
Q2 25
$57.6M
$39.3M
Q1 25
$49.4M
$20.7M
Q4 24
$9.5M
$30.5M
Q3 24
$35.6M
$19.4M
Q2 24
$61.2M
$-153.0M
Q1 24
$36.5M
$4.0M
Gross Margin
LCII
LCII
MD
MD
Q4 25
22.1%
Q3 25
24.4%
Q2 25
24.4%
Q1 25
24.1%
Q4 24
21.1%
Q3 24
24.0%
Q2 24
25.3%
Q1 24
23.1%
Operating Margin
LCII
LCII
MD
MD
Q4 25
3.8%
9.9%
Q3 25
7.3%
13.8%
Q2 25
7.9%
12.8%
Q1 25
7.8%
7.0%
Q4 24
2.0%
7.8%
Q3 24
5.9%
6.6%
Q2 24
8.6%
-31.3%
Q1 24
6.0%
3.2%
Net Margin
LCII
LCII
MD
MD
Q4 25
2.0%
6.8%
Q3 25
6.0%
14.5%
Q2 25
5.2%
8.4%
Q1 25
4.7%
4.5%
Q4 24
1.2%
6.1%
Q3 24
3.9%
3.8%
Q2 24
5.8%
-30.3%
Q1 24
3.8%
0.8%
EPS (diluted)
LCII
LCII
MD
MD
Q4 25
$0.79
$0.40
Q3 25
$2.55
$0.84
Q2 25
$2.29
$0.46
Q1 25
$1.94
$0.24
Q4 24
$0.37
$0.37
Q3 24
$1.39
$0.23
Q2 24
$2.40
$-1.84
Q1 24
$1.44
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCII
LCII
MD
MD
Cash + ST InvestmentsLiquidity on hand
$222.6M
$375.2M
Total DebtLower is stronger
$945.2M
$570.5M
Stockholders' EquityBook value
$1.4B
$865.9M
Total Assets
$3.2B
$2.2B
Debt / EquityLower = less leverage
0.69×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCII
LCII
MD
MD
Q4 25
$222.6M
$375.2M
Q3 25
$199.7M
$340.1M
Q2 25
$191.9M
$224.7M
Q1 25
$231.2M
$99.0M
Q4 24
$165.8M
$229.9M
Q3 24
$161.2M
$103.8M
Q2 24
$130.4M
$19.4M
Q1 24
$22.6M
$8.0M
Total Debt
LCII
LCII
MD
MD
Q4 25
$945.2M
$570.5M
Q3 25
$947.8M
$577.2M
Q2 25
$948.0M
$583.9M
Q1 25
$938.3M
$590.5M
Q4 24
$757.3M
$597.1M
Q3 24
$822.5M
Q2 24
$829.7M
Q1 24
$855.3M
Stockholders' Equity
LCII
LCII
MD
MD
Q4 25
$1.4B
$865.9M
Q3 25
$1.4B
$890.7M
Q2 25
$1.4B
$833.8M
Q1 25
$1.4B
$789.2M
Q4 24
$1.4B
$764.9M
Q3 24
$1.4B
$732.5M
Q2 24
$1.4B
$706.5M
Q1 24
$1.4B
$856.2M
Total Assets
LCII
LCII
MD
MD
Q4 25
$3.2B
$2.2B
Q3 25
$3.2B
$2.2B
Q2 25
$3.2B
$2.1B
Q1 25
$3.1B
$2.0B
Q4 24
$2.9B
$2.2B
Q3 24
$3.0B
$2.1B
Q2 24
$3.0B
$2.0B
Q1 24
$3.0B
$2.2B
Debt / Equity
LCII
LCII
MD
MD
Q4 25
0.69×
0.66×
Q3 25
0.70×
0.65×
Q2 25
0.68×
0.70×
Q1 25
0.69×
0.75×
Q4 24
0.55×
0.78×
Q3 24
0.58×
Q2 24
0.60×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCII
LCII
MD
MD
Operating Cash FlowLast quarter
$78.9M
$114.1M
Free Cash FlowOCF − Capex
$64.3M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
4.22×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$278.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCII
LCII
MD
MD
Q4 25
$78.9M
$114.1M
Q3 25
$97.2M
$137.3M
Q2 25
$112.2M
$137.2M
Q1 25
$42.7M
$-117.5M
Q4 24
$106.6M
$133.0M
Q3 24
$78.4M
$91.8M
Q2 24
$192.9M
$107.0M
Q1 24
$-7.7M
$-125.2M
Free Cash Flow
LCII
LCII
MD
MD
Q4 25
$64.3M
Q3 25
$80.9M
Q2 25
$99.5M
Q1 25
$33.7M
Q4 24
$95.7M
Q3 24
$68.3M
Q2 24
$180.2M
Q1 24
$-16.3M
FCF Margin
LCII
LCII
MD
MD
Q4 25
6.9%
Q3 25
7.8%
Q2 25
9.0%
Q1 25
3.2%
Q4 24
11.9%
Q3 24
7.5%
Q2 24
17.1%
Q1 24
-1.7%
Capex Intensity
LCII
LCII
MD
MD
Q4 25
1.6%
Q3 25
1.6%
Q2 25
1.2%
Q1 25
0.9%
Q4 24
1.4%
Q3 24
1.1%
Q2 24
1.2%
Q1 24
0.9%
Cash Conversion
LCII
LCII
MD
MD
Q4 25
4.22×
3.39×
Q3 25
1.55×
1.91×
Q2 25
1.95×
3.49×
Q1 25
0.86×
-5.66×
Q4 24
11.17×
4.36×
Q3 24
2.20×
4.72×
Q2 24
3.15×
Q1 24
-0.21×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LCII
LCII

Travel Trailer And Fifth Wheels$378.4M41%
Chassis Chassis Partsand Slideout Mechanisms$206.1M22%
Furnitureand Mattresses$120.4M13%
Appliances$69.9M7%
Other Products$69.1M7%
Axlesand Suspension Solutions$62.3M7%
Motorhomes$34.2M4%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons